申请人:SHENZHEN IMMUNOVA PHARMACEUTICAL CO., LTD.
公开号:US20190330201A1
公开(公告)日:2019-10-31
The disclosure discloses an aryl hydrocarbon receptor modulators of formula (I), and pharmaceutically acceptable salts,
R′ is H, CN, CH
2
(OH)R
0
, C
m
H
2m+1
, C
n
H
2n-1
, C
n
H
2n-3
,
two R
a
is independently H, or two R
a
together form ═O or ═N—W
3
—R
1
; A is a C
6
to C
10
aromatic ring, or a C
2
to C
10
heteroaromatic ring containing 1 to 5 heteroatom from N, O and S, or 4 to 7 membered non-aromatic heterocyclic ring containing 1 to 3 heteroatom from N, O and S and C═N, which are with no substituent or substituted by 1 or 3 R; Q is R, or a C
6
to C
10
aromatic ring or a C
2
to C
10
heteroaromatic ring containing 1 to 5 heteroatom selected from N, O and S, which are with no substituent or substituted by 1 or 3 R; R is R
c
connected with C or R
N
connected with N.